ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000

AACR settles dispute with Toronto Convention Center and hotels over cancellation of 2003 annual meeting. Travelers Insurance covered AACR’s claim.

April 15, 2005

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012